Project description
Unifying Europe’s network for biomedical innovation
Despite Europe’s world-class science, promising biomedical discoveries often fail to reach patients due to fragmented support and limited cross-border collaboration. The EU-funded TransBioNet project will address this gap by establishing the first pan-European network of knowledge valorisation intermediaries. The project aims to create a coherent ecosystem by connecting regional clusters and providing flagship resources, including a central digital platform and a standardised assessment toolkit. Furthermore, TransBioNet will train a new generation of skilled professionals and support 12 drug discovery projects through mentoring and open calls. By de-risking research, the project is expected to strengthen European competitiveness and ensure that scientific excellence translates into innovative therapies and lasting societal impact.
Objective
TransBioNet will establish the first pan-European network of knowledge valorisation intermediaries fully dedicated to drug discovery and biomedical innovation. Despite Europe’s world-class science, promising discoveries often fail to reach patients due to fragmented support, under-recognised intermediaries, and limited cross-border collaborations. TransBioNet addresses this gap by connecting regional clusters, pan-European infrastructures, and accelerators into a coherent ecosystem that equips intermediaries with harmonised tools, training, and services.
The project will deliver three flagship resources: (i) the TransBioNet Digital Platform, a central hub integrating the Infrastructure Atlas, matchmaking tools, and training modules; (ii) a Valorisation Assessment Toolkit, providing standardised TRL/IRL evaluations embedding regulatory, IP, and market dimensions; and (iii) the TransBioNet Charter, a policy framework to ensure recognition of intermediaries across EU and national innovation strategies. Two Open Calls will support 12 early-stage drug discovery projects with mentoring, bootcamps, and access to infrastructures, creating tangible case studies of valorisation in practice.
Through training programmes, secondments, and a Community of Practice, the project will build a new generation of skilled intermediaries able to de-risk biomedical projects, improve reproducibility, and accelerate translation. By lowering attrition rates and increasing investment readiness, TransBioNet will strengthen Europe’s competitiveness in drug discovery while ensuring inclusive participation of less-resourced regions.
The project directly advances ERA Action 7 on Knowledge Valorisation, reinforcing open science, responsible research assessment, and cross-border collaboration. By its conclusion, TransBioNet will deliver a recognised European reference point for biomedical valorisation, ensuring that high-quality science translates into innovative therapies, jobs & societal impact.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.4.2 - Reforming and enhancing the European R&I System
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-CSA - HORIZON Coordination and Support Actions
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-WIDERA-2025-06
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
3060-197 Cantanhede
Portugal
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.